The link debunks and refute your nonsensical statement here:
UCLA is running a P1/2 with a similar but different DC vaccine that has these agents combined.
We can only speculate about your incentives for having wasted a decade of your life and thousands of hours of others BS’ing here daily.
When UCLA uses the term ATL-DC in a clinical trial, it is DCVax-L. Not ATL-DC1 or anything “almost the same”.
The term ATL-DC mentioned in a UCLA clinical trial IS DCVax-L.
It means so much for paid shills to FUD about this, that even Adam Feuerstein had to denigrate himself to make up a nonsensical story, because if the reality went viral, that DCVax-L is in a combo trial with Keytruda showing around 65% efficacy in interim results, shown at a slide in the Al Musella/Liau webinar December 5th. 2022 - and taken down hours later - the share price would never have been able to suppress.
A webinar I have all slides to, the full video and a full transcript.
As Liau say:
Time is running out. Proportional to the quality of your FUD.
